Pfizer's tofacitinib review backburnered for three months
August 21 2012
The drugmaker said Tuesday that, as expected, the FDA has delayed review of its rheumatoid arthritis medication.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.